• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自自微乳化药物递送系统和溶液的放射性和非放射性利塞膦酸钠的渗透性比较研究。

Comparative permeability studies with radioactive and nonradioactive risedronate sodium from self-microemulsifying drug delivery system and solution.

作者信息

Ilem-Ozdemir Derya, Gundogdu Evren, Ekinci Meliha, Ozgenc Emre, Asikoglu Makbule

机构信息

a Department of Radiopharmacy, Faculty of Pharmacy , Ege University , Bornova, Izmir , Turkey.

出版信息

Drug Dev Ind Pharm. 2015;41(9):1493-8. doi: 10.3109/03639045.2014.959022. Epub 2015 Jul 21.

DOI:10.3109/03639045.2014.959022
PMID:25285358
Abstract

The purpose of this work is to prepare a self-microemulsifying drug delivery system (SMEDDS) for risedronate sodium (RSD) and to compare the permeability with RSD solution. The solubility of RSD was determined in different vehicles. Phase diagrams were constructed to determine the optimum concentration of oil, surfactant, and cosurfactant. RSD SMEDDS was prepared by using a mixture of soybean oil, cremophor EL, span 80, and transcutol (2.02:7.72:23.27:61.74, w/w, respectively). The prepared RSD SMEDDS was characterized by droplet size value. In vitro Caco-2 cell permeability studies were performed for SMEDDS and solution of radioactive ((99 m)Tc-labeled RSD) and nonradioactive RSD. The experimental results indicated that RSD SMEDDS has good stability and its droplet size is between 216.68 ± 3.79 and 225.26 ± 7.65 during stability time. In addition, RSD SMEDDS has higher permeability value than the RSD solution for both radioactive and nonradioactive experiments. The results illustrated the potential use of SMEDDS for delivery of poorly absorbed RSD.

摘要

本研究旨在制备利塞膦酸钠(RSD)的自微乳化药物递送系统(SMEDDS),并与RSD溶液的渗透性进行比较。测定了RSD在不同载体中的溶解度。构建相图以确定油、表面活性剂和助表面活性剂的最佳浓度。采用大豆油、聚氧乙烯蓖麻油EL、司盘80和二乙二醇单乙基醚(比例分别为2.02:7.72:23.27:61.74,w/w)的混合物制备了RSD SMEDDS。通过液滴尺寸值对所制备的RSD SMEDDS进行表征。对SMEDDS以及放射性((99m)Tc标记的RSD)和非放射性RSD的溶液进行了体外Caco-2细胞渗透性研究。实验结果表明,RSD SMEDDS具有良好的稳定性,在稳定期内其液滴尺寸在216.68±3.79至225.26±7.65之间。此外,在放射性和非放射性实验中,RSD SMEDDS的渗透性值均高于RSD溶液。结果表明SMEDDS在递送吸收不良的RSD方面具有潜在应用价值。

相似文献

1
Comparative permeability studies with radioactive and nonradioactive risedronate sodium from self-microemulsifying drug delivery system and solution.来自自微乳化药物递送系统和溶液的放射性和非放射性利塞膦酸钠的渗透性比较研究。
Drug Dev Ind Pharm. 2015;41(9):1493-8. doi: 10.3109/03639045.2014.959022. Epub 2015 Jul 21.
2
Tc-99m Radiolabeled Alendronate Sodium Microemulsion: Characterization and Permeability Studies Across Caco-2 Cells.锝-99m 放射性标记阿仑膦酸钠微乳剂:特性及跨 Caco-2 细胞的渗透性研究
Curr Drug Deliv. 2018;15(3):342-350. doi: 10.2174/1567201814666170613082752.
3
Solid self-microemulsifying drug delivery system of ritonavir.利托那韦固体自微乳药物传递系统。
Drug Dev Ind Pharm. 2014 Apr;40(4):477-87. doi: 10.3109/03639045.2013.768632. Epub 2013 Mar 7.
4
Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.含阿托伐他汀的自微乳化药物递送系统(SMEDDS)的制备与评价
J Pharm Pharmacol. 2006 Sep;58(9):1183-91. doi: 10.1211/jpp.58.9.0004.
5
Development of a solid self-microemulsifying drug delivery system (SMEDDS) for solubility enhancement of naproxen.开发一种用于提高萘普生溶解度的固体自微乳化药物递送系统(SMEDDS)。
Drug Dev Ind Pharm. 2015;41(9):1548-57. doi: 10.3109/03639045.2014.971031. Epub 2015 Jul 14.
6
Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.难溶性药物氯诺昔康口服自乳化系统的制备及药代动力学评价
Drug Deliv. 2015;22(4):487-98. doi: 10.3109/10717544.2014.885615. Epub 2014 Feb 13.
7
Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate.基于质量源于设计理念开发自微乳化药物递送系统以降低食物对甲磺酸奈非那韦的影响。
Int J Pharm. 2016 Mar 30;501(1-2):311-25. doi: 10.1016/j.ijpharm.2016.02.008. Epub 2016 Feb 6.
8
Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.混合脂质相 SMEDDS 作为一种提高白藜芦醇溶解度的创新方法。
Drug Dev Ind Pharm. 2014 Jan;40(1):102-9. doi: 10.3109/03639045.2012.749888. Epub 2013 Jan 10.
9
Novel bicephalous heterolipid based self-microemulsifying drug delivery system for solubility and bioavailability enhancement of efavirenz.新型双头异质脂基自微乳给药系统提高依非韦伦的溶解度和生物利用度。
Int J Pharm. 2019 Apr 5;560:205-218. doi: 10.1016/j.ijpharm.2019.01.065. Epub 2019 Feb 10.
10
Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.含有长春西汀的自微乳化药物递送系统的制备与评价
Drug Dev Ind Pharm. 2009 May;35(5):603-11. doi: 10.1080/03639040802488089.

引用本文的文献

1
Valsartan Loaded Solid Self-Nanoemulsifying Delivery System to Enhance Oral Absorption and Bioavailability.缬沙坦固体自纳米乳化给药系统用于增强口服吸收和生物利用度。
AAPS PharmSciTech. 2025 Jan 23;26(1):45. doi: 10.1208/s12249-024-03032-0.
2
Radiolabeling, Quality Control, and Cell Binding Studies of New Tc-Labeled Bisphosphonates: Tc-Ibandronate Sodium.新型锝标记双膦酸盐:锝-伊班膦酸钠的放射性标记、质量控制及细胞结合研究
Turk J Pharm Sci. 2023 May 9;20(2):91-99. doi: 10.4274/tjps.galenos.2022.01346.
3
Investigation on Potential of Chitosan Nanoparticles for Oral Bioavailability Enhancement of Risedronate Sodium.
壳聚糖纳米粒提高利塞膦酸钠口服生物利用度的潜力研究。
AAPS PharmSciTech. 2021 Sep 17;22(7):236. doi: 10.1208/s12249-021-02090-y.
4
Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation.依达拉奉脂质纳米系统:研发、优化、表征及体外/体内评价
Drug Deliv. 2017 Nov;24(1):962-978. doi: 10.1080/10717544.2017.1337825.